Literature DB >> 23960323

Giant median nerve in bilateral carpal tunnel syndrome.

Hosein Ahmadzadeh Chabok1.   

Abstract

We introduce a middle age healthy man with sequential bilateral carpal tunnel syndrome. At the surgery, we encountered a wide median nerve in both wrists. Although enlargement of median nerve in carpal tunnel has been well documented, 25 mm width of the nerve is a rare scene, underscoring that leaving the nerve under the unyielding pressure would lead to a fibrous atrophic median nerve.

Entities:  

Keywords:  Blood-nerve barrier; carpal tunnel syndrome; compressive neuropathy; median nerve; neural edema

Year:  2013        PMID: 23960323      PMCID: PMC3745103          DOI: 10.4103/0970-0358.113735

Source DB:  PubMed          Journal:  Indian J Plast Surg        ISSN: 0970-0358


INTRODUCTION

Carpal tunnel syndrome is the most common entrapment neuropathy involving the median nerve under the unyielding fibrous transverse carpal ligament. Acute or chronic elevation of carpal tunnel pressure may lead to carpal tunnel syndrome.[12] Surgical release of carpal tunnel is an effective treatment and in substantial majority, surgery is necessary to relieve the symptoms efficiently.[12]

CASE REPORT

An otherwise healthy 41-year-old patient presented to our orthopaedic clinic with wrist pain. He was secretary of an office with a heavy writing job and a recently sudden increase in his duty without a chance to reduce his heavy working load. He had no important sign and symptom but a localised pain at the volar surface of the wrist of his right dominant hand. A ten days course of NSAID was prescribed. Three weeks later, he came back with more severe pain at the wrist and we advised him to immobilise the wrist with a volar wrist splint and another two weeks of NSAID therapy. One month later, he returned with a localised swelling on the volar aspect of the wrist, numbness and tingling on the palmar surface of the entire hand and a burning pain radiating proximally to the forearm. Electrodiagnostic evaluation revealed moderate to severe median nerve neuropathy at the wrist suggestive of carpal tunnel syndrome. Since the symptoms were not typical for carpal tunnel syndrome in order to exclude unusual etiologies, we suggested a wrist MRI which revealed median nerve swelling and notable edema in carpal tunnel. We planned open surgical release of the carpal tunnel with a classical incision at the wrist. At the surgery, we were surprised of a wide 25-mm swollen median nerve occupying nearly entire width of the carpal tunnel with tiny surface vessels [Figure 1]. Transverse carpal ligament was incised. To prevent recurrence, 2 mm of the ligament was excised. The patient experienced a painless post operation period and soon returned to work.
Figure 1

Sizable, swollen median nerve of right dominant hand. Median nerve is obviously edematous and occupies nearly all width of the carpal tunnel

Sizable, swollen median nerve of right dominant hand. Median nerve is obviously edematous and occupies nearly all width of the carpal tunnel Eleven months later, he came back to our clinic with a painful fusiform swelling along the palmar aspect of the middle finger extending to the palm of the left hand. We advised him to give a rest to his hand and a 10 days course of NSAID therapy; with good response and subsidence of swelling. Three weeks later, he was suffering from a severe pain and mild swelling at the volar surface of the left wrist with tingling and numbness on the palmar surface of all digits. The pain was burning in nature and radiating up to the forearm. Having previous history in mind, after an electrodiagnostic evaluation suggestive of carpal tunnel syndrome, we planned open surgical release of transverse carpal tunnel ligament as soon as possible. We observed a sizable swollen median nerve about the same size as in the other hand occupying the entire width of the carpal tunnel [Figures 2 and 3]. After incising transverse carpal ligament, we excised 2-mm width of the ligament. Symptoms completely relieved after the surgery and he returned to previous job. Thirty-two months after the first surgery and nineteen months after the second surgery, the patient had no pain, no swelling and no neurological symptoms and objective signs of sensory deficits, weakness and/or thenar muscle atrophy.
Figure 2

Giant swollen median nerve with venous engorgement in left hand

Figure 3

Notice the size of edematous median nerve in proportion to palmaris longus tendon in left hand

Giant swollen median nerve with venous engorgement in left hand Notice the size of edematous median nerve in proportion to palmaris longus tendon in left hand

DISCUSSION

High carpal tunnel pressure compromises median nerve electrophysiological functions leading to a package of signs and symptoms recognised as carpal tunnel syndrome.[12] Postural factors including non-neutral wrist posture, forceful repetitive hand-work and vibration are some predisposing factors elevating carpal tunnel pressure but in majority, there is no identifiable cause.[134] High carpal tunnel pressure as an external load initiates some internal responses leading to other various responses in the nerve (cascade model). First, high pressure as a compression trauma increases permeability of epineurial vessels leading to epineurial edema. Epineurial blood vessels are more vulnerable to trauma but with exceeding pressure, breakdown of blood-nerve barrier in endoneurial microvessels leads to endoneurial edema and high endoneurial pressure. Blood-nerve barrier is a principal structure controlling endoneurial milieu. Since endoneurial space lacks lymphatics and for selective diffusion barrier formed by epineurial membrane, edema cannot be drained out. Edema reduces endoneurial microcirculation through occluding openings in perineurial membrane where the anastomosing vessels between epineurium and endoneurium pass obliquely (valve mechanism). Resultant ischemia induces other events.[12345] Second, high pressure reduces epineurial venule flow. Increasing pressure compromises arteriolar flow and endoneurial capillary blood flow; consequently, ischemia occurs.[345] Cyclic Ischemia and reperfusion as an ischemic stress releases overwhelming free oxygen radicals, malonaldehyde bis (diethyl acetal). Continued oxidative stress and resultant free oxygen radicals lead to cellular injury in the nerve and synovial tissue.[267] Cellular injury initiates the metabolism of arachidonic acid to cyclooxygenase products such as PGE2. This product as a potent vasodilator enhances vascular permeability and also sensitises nerve endings to mechanical and chemical stimuli, so that normal stimulus can be painful. Tissue levels of PGE2 and malonaldehyde bis (diethyl acetal) in patients with carpal tunnel syndrome are significantly higher than normal. Cellular damage contributes to production of cytokines (as IL6) that originate fibroblast proliferation and fibrosis in connective tissue container of the nerve. It has been demonstrated that tissue levels of IL6 in patients with carpal tunnel syndrome is highly elevated.[678] Formation of fibrosis decreases excursion of nerve fibers and neural gliding, producing dynamic ischemia. These serial of events construct a cascade model of responses and a vicious circle. The end result of this sequence of events would be nerve fibers atrophy massive fibrous changes of soft tissue container of the nerve with permanent nerve injury.[89] Cross-section area of the median nerve in carpal tunnel in asymptomatic adults has been measured less than 10 mm2 with Sonographic evaluation. Although enlargement of median nerve in carpal tunnel syndrome due to edema has been demonstrated by sonography in various studies, to our knowledge, this amount of enlargement (25 mm wide), as defined in our case, has never been reported.[10] This huge amount of edema leaving the nerve under the unyielding pressure may very soon develop to a nerve ischemia and subsequent necrosis leading to a fibrous atrophic median nerve. Prompt surgical release of carpal tunnel interrupts the process, alleviates the symptoms and promises good results.
  10 in total

Review 1.  Pathophysiology of nerve compression syndromes: response of peripheral nerves to loading.

Authors:  D Rempel; L Dahlin; G Lundborg
Journal:  J Bone Joint Surg Am       Date:  1999-11       Impact factor: 5.284

Review 2.  Role of physical load factors in carpal tunnel syndrome.

Authors:  E Viikari-Juntura; B Silverstein
Journal:  Scand J Work Environ Health       Date:  1999-06       Impact factor: 5.024

3.  Biochemical and histological analysis of the flexor tenosynovium in patients with carpal tunnel syndrome.

Authors:  M A Tucci; R A Barbieri; A E Freeland
Journal:  Biomed Sci Instrum       Date:  1997

Review 4.  Pathophysiology of nerve compression.

Authors:  Susan E Mackinnon
Journal:  Hand Clin       Date:  2002-05       Impact factor: 1.907

Review 5.  Biochemistry of carpal tunnel syndrome.

Authors:  Vipul Sud; Alan E Freeland
Journal:  Microsurgery       Date:  2005       Impact factor: 2.425

6.  Pathology of experimental compression neuropathy producing hyperesthesia.

Authors:  C Sommer; J A Galbraith; H M Heckman; R R Myers
Journal:  J Neuropathol Exp Neurol       Date:  1993-05       Impact factor: 3.685

7.  Nerve compression injury and increased endoneurial fluid pressure: a "miniature compartment syndrome".

Authors:  G Lundborg; R Myers; H Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-12       Impact factor: 10.154

8.  Ultrasound evaluation of patients with carpal tunnel syndrome before and after endoscopic release of the transverse carpal ligament.

Authors:  C A Abicalaf; N de Barros; R A Sernik; B F Pimentel; A Braga-Baiak; L Braga; P Houvet; J-L Brasseur; B Roger; G G Cerri
Journal:  Clin Radiol       Date:  2007-06-15       Impact factor: 2.350

9.  Compressive neuropathy in the upper limb.

Authors:  Mukund R Thatte; Khushnuma A Mansukhani
Journal:  Indian J Plast Surg       Date:  2011-05

Review 10.  Carpal tunnel syndrome.

Authors:  Somaiah Aroori; Roy A J Spence
Journal:  Ulster Med J       Date:  2008-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.